Cargando…

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone

Detalles Bibliográficos
Autores principales:	Römer, Thomas, Bitzer, Johannes, Egarter, Christian, Hadji, Peyman, Kiechle, Marion, Kramer, Heike, Oppelt, Patricia G., Peters, Klaus, Stute, Petra, Schaudig, Katrin, Wiegratz, Inka, Regidor, Pedro-Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738085/ https://www.ncbi.nlm.nih.gov/pubmed/36510503 http://dx.doi.org/10.1055/a-1536-7577

Ejemplares similares

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

The Impact of Progestin-only Contraception on Adolescents with Macromastia
por: Nuzzi, Laura C., et al.
Publicado: (2021)

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
por: Palacios, Santiago, et al.
Publicado: (2019)

A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen()()
por: Kimble, Thomas, et al.
Publicado: (2020)

Drospirenone/ethinyl estradiol 3 mg/20 μg (24/4 day regimen): hormonal contraceptive choices – use of a fourth-generation progestin
por: Bachmann, Gloria, et al.
Publicado: (2009)

Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, S., et al.
Publicado: (2020)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

A rodent model of human dose-equivalent progestin-only implantable contraception
por: Allaway, Heather C. M., et al.
Publicado: (2021)

Enhanced ZBTB16 Levels by Progestin-Only Contraceptives Induces Decidualization and Inflammation
por: Arlier, Sefa, et al.
Publicado: (2023)

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
por: Palacios, Santiago, et al.
Publicado: (2020)

A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, Santiago, et al.
Publicado: (2019)

Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States
por: Grindlay, Kate, et al.
Publicado: (2022)

Correction to: A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, Santiago, et al.
Publicado: (2020)

Intercellular adhesion molecule-1 expression in human endometrium: implications for long term progestin only contraception
por: Schatz, Frederick, et al.
Publicado: (2006)

Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
por: Mantha, S, et al.
Publicado: (2012)

Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis
por: Glisic, Marija, et al.
Publicado: (2018)

Evaluating the Cognitive Impacts of Drospirenone, a Spironolactone-Derived Progestin, Independently and in Combination With Ethinyl Estradiol in Ovariectomized Adult Rats
por: Koebele, Stephanie V., et al.
Publicado: (2022)

The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
por: Shoupe, Donna
Publicado: (2023)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial
por: Regidor, P.-A., et al.
Publicado: (2022)

Effects of progestin-only contraceptives on the phenotype and function of female reproductive tract CD4+ and CD8+ T cells
por: Shanmugasundaram, Uma, et al.
Publicado: (2014)

Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans
por: Sarna, Magdalena A., et al.
Publicado: (2009)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
por: Shamseddin, Marie, et al.
Publicado: (2021)

The efficacy, acceptability and continuation of postpartum, post-abortive progestin-only pill: a pioneering prospective multicentric study from Turkey
por: Dilbaz, Berna, et al.
Publicado: (2022)

Progestins and mammary cancer induction.
por: Coezy, E., et al.
Publicado: (1973)

Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study
por: Edelman, Alison, et al.
Publicado: (2021)

Progestins and the endometrium in patients receiving tamoxifen
Publicado: (1999)

Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release
por: Herrera, Alexandra Ycaza, et al.
Publicado: (2019)

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa
por: Noguchi, Lisa M., et al.
Publicado: (2021)

Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins
por: da Costa Pinheiro, Denise Joffily Pereira, et al.
Publicado: (2023)

Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study
por: Wiegratz, Inka, et al.
Publicado: (2015)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study
por: Smith, Keisha, et al.
Publicado: (2018)

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019)

Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study
por: Bjelland, Elisabeth Krefting, et al.
Publicado: (2017)

Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study
por: Shiferaw, Mulu, et al.
Publicado: (2021)

Comparison of the Effects of Hysteroscopic Cold Broad Sword Play Combined with Estrogen and Progestin Sequential Therapy and Drospirenone and Ethinylestradiol Tablets in Patients with Severe Intrauterine Adhesion
por: Zhou, Liping, et al.
Publicado: (2022)

Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
por: Iwata, Masaru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mqelc9e4l8s25o7nm9jiblif91